Fidelio has acquired a majority stake in Alphalyse, a Danish specialist contract research organisation (CRO) focused on liquid-chromatography mass-spectrometry (LC-MS) based analytics.

With a fully validated, scalable platform aligned with the latest regulatory standards, Alphalyse is driving a structural shift in the industry away from ELISA-based methods. In partnership with the founders, Fidelio will support the company’s international expansion and continued growth as a global reference in HCP analysis.